Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company. Company to hold a virtual conference call ...
ProPhase Labs, Inc. (OTC: PRPH) ("ProPhase” or the "Company”), a next-generation biotech, genomics and consumer products company, today reported its financial results for the year ended December 31, ...
UNIONDALE, NY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and consumer products company, today announced ...
(RTTNews) - ProPhase Labs, Inc. (PRPH) announced that its common stock has successfully uplisted from the Pink Sheets to the OTC Market, marking a step forward in the company's efforts to enhance ...
ProPhase Labs (PRPH) has initiated a potential sale or strategic partnership process for BE-Smart, its clinically validated esophageal cancer risk stratification test. As part of this process, ...
ProPhase Labs Inc. (Nasdaq: PRPH), a biotech firm with plans to build a crypto treasury, announced on Sep. 23 that its three COVID-19 testing lab units have filed for reorganization under Chapter 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results